HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: stemcells.2007-0528v1 26/2/562    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Traggiai, E. Articles by Martini, A. Search for Related Content PubMed PubMed Citation Articles by Traggiai, E. Articles by Martini, A.

TRANSLATIONAL AND CLINICAL RESEARCH

Bone Marrow-Derived Mesenchymal Stem Cells Induce Both Polyclonal Expansion and Differentiation of B Cells Isolated from Healthy Donors and Systemic Lupus Erythematosus Patients

^aSecond Division of Pediatrics, IRCCS, Institute G. Gaslini, Genova, Italy;
^bCenter of Excellence for Biomedical Research, Genova, Italy;
^cUniversity of Genova, Genova, Italy

Key Words. Mesenchymal stem cells • B-cell subsets • Systemic autoimmunity • Polyclonal stimulation

Correspondence: Correspondence: Elisabetta Traggiai, Ph.D., Istituto Giannina Gaslini, Largo Gerolamo Gaslini 5, 16147 Genova, Italy. Telephone: 39-010-353-3065; Fax: 39-010-353-3025; e-mail: elisabetta.traggiai{at}gmail.com

Received on July 4, 2007; accepted for publication on November 5, 2007.

First published online in STEM CELLS EXPRESS  November 15, 2007.


Human bone marrow multipotent mesenchymal stromal cells are progenitor cells that can be expanded in vitro and differentiate into various cells of mesodermal origin. They contribute to the bone marrow reticular niche, where mature B cells and long-lived plasma cells are maintained. Multipotent mesenchymal stromal cells were recently shown to modulate T- and B-cell proliferation and differentiation, dendritic cell maturation, and natural killer activity. These immunoregulatory properties encouraged a possible use of these cells to modulate autoimmune responses in humans. We studied the influence of bone marrow mesenchymal stem cells on highly purified B-cell subsets isolated from healthy donors and total B cells from pediatric systemic lupus erythematosus patients. Bone marrow mesenchymal stem cells promoted proliferation and differentiation into immunoglobulin-secreting cells of transitional and naïve B cells stimulated with an agonist of Toll-like receptor 9, in the absence of B cell receptor triggering. They strongly enhanced proliferation and differentiation into plasma cells of memory B-cell populations. A similar effect was observed in response to polyclonal stimulation of B cells isolated from pediatric patients with systemic lupus erythematosus. This study casts important questions on bone marrow mesenchymal stem cells as a therapeutic tool in autoimmune diseases in which B-cell activation is crucially implicated in the pathogenesis of the disease.

Disclosure of potential conflicts of interest is found at the end of this article.

This article has been cited by other articles:

				A Tyndall Cellular therapy of systemic lupus erythematosus Lupus, April 1, 2009; 18(5): 387 - 393. [Abstract] [PDF]

				H. Maby-El Hajjami, P. Ame-Thomas, C. Pangault, O. Tribut, J. DeVos, R. Jean, N. Bescher, C. Monvoisin, J. Dulong, T. Lamy, et al. Functional Alteration of the Lymphoma Stromal Cell Niche by the Cytokine Context: Role of Indoleamine-2,3 Dioxygenase Cancer Res., April 1, 2009; 69(7): 3228 - 3237. [Abstract] [Full Text] [PDF]

				M. A. Haniffa, M. P. Collin, C. D. Buckley, and F. Dazzi Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica, February 1, 2009; 94(2): 258 - 263. [Abstract] [Full Text] [PDF]